Jinping Gan

2.6k total citations
61 papers, 1.7k citations indexed

About

Jinping Gan is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Jinping Gan has authored 61 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 20 papers in Molecular Biology and 17 papers in Pharmacology. Recurrent topics in Jinping Gan's work include Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Jinping Gan is often cited by papers focused on Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Jinping Gan collaborates with scholars based in United States, Germany and Sweden. Jinping Gan's co-authors include W. Griffith Humphreys, Kennon M. Garrett, Hong Shen, Donglu Zhang, Timothy W. Harper, Paul L. Skipper, Kan He, Punit Marathe, Weiqi Chen and Haiying Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jinping Gan

58 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jinping Gan United States	22	569	466	436	228	179	61	1.7k
Andreas Reichel Germany	25	738 1.3×	755 1.6×	233 0.5×	183 0.8×	243 1.4×	88	2.6k
Lena Gustavsson Sweden	24	1.0k 1.8×	453 1.0×	350 0.8×	178 0.8×	234 1.3×	58	2.5k
Marcella Martignoni Italy	12	546 1.0×	646 1.4×	684 1.6×	134 0.6×	108 0.6×	22	1.8k
Bill J. Smith United States	20	467 0.8×	697 1.5×	348 0.8×	54 0.2×	327 1.8×	28	1.6k
Zhiyang Zhao United States	22	675 1.2×	260 0.6×	283 0.6×	77 0.3×	40 0.2×	66	1.5k
Markus Fridén Sweden	20	442 0.8×	772 1.7×	169 0.4×	110 0.5×	353 2.0×	40	1.7k
Tamihide Matsunaga Japan	26	680 1.2×	519 1.1×	614 1.4×	304 1.3×	139 0.8×	144	2.2k
Yanping Sun China	23	932 1.6×	516 1.1×	228 0.5×	71 0.3×	106 0.6×	114	2.6k
Theresia Thalhammer Austria	29	837 1.5×	662 1.4×	204 0.5×	70 0.3×	165 0.9×	79	2.4k
Stephen E. Clarke United Kingdom	22	701 1.2×	351 0.8×	926 2.1×	87 0.4×	108 0.6×	42	2.3k

Countries citing papers authored by Jinping Gan

Since Specialization

Citations

This map shows the geographic impact of Jinping Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinping Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinping Gan more than expected).

Fields of papers citing papers by Jinping Gan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinping Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinping Gan. The network helps show where Jinping Gan may publish in the future.

Co-authorship network of co-authors of Jinping Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Jinping Gan. A scholar is included among the top collaborators of Jinping Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinping Gan. Jinping Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miguel, M. De, Víctor Moreno, Jessica Menis, et al.. (2024). 1006P Phase I dose escalation study of HFB200603, a best-in-class BTLA antagonist monoclonal antibody (mAb), in monotherapy and in combination with the anti-PD-1 mAb tislelizumab (TIS) in adult patients (pts) with advanced solid tumors. Annals of Oncology. 35. S684–S684.

Gan, Jinping, Pan Cheng, Qin Cheng, et al.. (2024). Ethylene Vinyl Alcohol Copolymer Nanofibrous Cation Exchange Chromatographic Membranes with a Gradient Porous Structure for Lysozyme Separation. Polymers. 16(8). 1112–1112. 4 indexed citations

Roda, Desamparados, Jon Zugazagoitia, Elena Garralda, et al.. (2024). Phase I dose escalation trial of the first-in-class TNFR2 agonist monoclonal antibody, HFB200301, in monotherapy and in combination with tislelizumab, an anti-PD-1 monoclonal antibody, in adult patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2526–2526.

Spira, Alexander I., Ranee Mehra, Charlene Mantia, et al.. (2022). 783TiP Phase I study of HFB301001, a novel OX40 agonist monoclonal antibody, in patients with solid tumors selected via Drug Intelligence Science (DIS). Annals of Oncology. 33. S899–S899. 2 indexed citations

Fowler, Stephen, David B. Duignan, Anshul Gupta, et al.. (2020). Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization. Lab on a Chip. 20(3). 446–467. 78 indexed citations

Hedrich, William D., Shen-Jue Chen, Brian W. Strassle, et al.. (2020). Development and characterization of rat duodenal organoids for ADME and toxicology applications. Toxicology. 446. 152614–152614. 14 indexed citations

Chen, Weiqi, Yueping Zhang, Michael Sinz, et al.. (2019). Enhanced and Persistent Inhibition of Organic Cation Transporter 1 Activity by Preincubation of Cyclosporine A. Drug Metabolism and Disposition. 47(11). 1352–1360. 15 indexed citations

Shen, Hong, David M. Nelson, Regina V. Oliveira, et al.. (2017). Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys. Drug Metabolism and Disposition. 46(2). 178–188. 38 indexed citations

Shen, Hong, Lifei Wang, Weiqi Chen, et al.. (2016). Tissue distribution and tumor uptake of folate receptor–targeted epothilone folate conjugate, BMS-753493, in CD2F1 mice after systemic administration. Acta Pharmaceutica Sinica B. 6(5). 460–467. 17 indexed citations

10.

Cheng, Yaofeng, Thomas F. Woolf, Jinping Gan, & Kan He. (2015). In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review. Chemico-Biological Interactions. 255. 23–30. 26 indexed citations

11.

Zhang, Donglu, Kan He, John J. Herbst, et al.. (2013). Characterization of Efflux Transporters Involved in Distribution and Disposition of Apixaban. Drug Metabolism and Disposition. 41(4). 827–835. 111 indexed citations

12.

Fevig, John M., Karen A. Rossi, Keith J. Miller, et al.. (2012). Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists. Bioorganic & Medicinal Chemistry Letters. 23(1). 330–335. 10 indexed citations

13.

Gong, Jiachang, Jinping Gan, Janet Caceres‐Cortes, et al.. (2011). Metabolism and Disposition of [14C]Brivanib Alaninate after Oral Administration to Rats, Monkeys, and Humans. Drug Metabolism and Disposition. 39(5). 891–903. 13 indexed citations

14.

Shen, Hong, et al.. (2011). Ixabepilone, a Novel Microtubule-Targeting Agent for Breast Cancer, Is a Substrate for P-Glycoprotein (P-gp/MDR1/ABCB1) but not Breast Cancer Resistance Protein (BCRP/ABCG2). Journal of Pharmacology and Experimental Therapeutics. 337(2). 423–432. 32 indexed citations

15.

Gan, Jinping, Weiqi Chen, Hong Shen, et al.. (2010). Repaglinide‐gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism. British Journal of Clinical Pharmacology. 70(6). 870–880. 34 indexed citations

16.

Foster, William R., Bruce D. Car, Hong Shi, et al.. (2010). Drug safety is a barrier to the discovery and development of new androgen receptor antagonists. The Prostate. 71(5). 480–488. 92 indexed citations

17.

Chang, Shu‐Ying, et al.. (2009). Mechanism-based inhibition of human cytochrome P4503A4 by domperidone. Xenobiotica. 40(2). 138–145. 12 indexed citations

18.

Ahmad, Saleem, Khehyong Ngu, Keith J. Miller, et al.. (2009). Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents. Bioorganic & Medicinal Chemistry Letters. 20(3). 1128–1133. 13 indexed citations

19.

Gan, Jinping, et al.. (2008). Troglitazone Thiol Adduct Formation in Human Liver Microsomes: Enzyme Knietics and Reaction Phenotyping. Drug Metabolism Letters. 2(3). 184–189. 2 indexed citations

20.

Gan, Jinping, Paul L. Skipper, Manuela Gago-Domínguez, et al.. (2004). Alkylaniline-Hemoglobin Adducts and Risk of Non-Smoking-Related Bladder Cancer. JNCI Journal of the National Cancer Institute. 96(19). 1425–1431. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact